Caplight Directory>Companies>Oncostellae-preview>Oncostellae


Oncostellae

Oncostellae

Private
Santiago de CompostelaHealthcare & Life Scienceshttps://oncostellae.com/

Last Round

Grant

Jul 1, 2025

Est. Valuation

$18.85M

Total Funding Raised

$3.67M

Company Overview

Oncostellae is a clinical-stage biopharmaceutical company that discovers and develops proprietary drug candidates for high unmet medical needs in immunology and oncology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

small molecule drug discoveryJAK inhibitordrug licensingclinical-stage biotechInflammatory Bowel DiseaseIBD treatmentgut-restricted drugoncology therapeuticsimmune-inflammatory diseasesearly-stage clinical trialsnew chemical entitiesNCEsulcerative colitisfibrosis treatmentARK5 inhibitorGR/PR antagonist

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Oncostellae Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Oncostellae Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantJul 1, 2025
Series AMar 18, 2024
VC RoundJul 5, 2023
VC RoundNov 22, 2022
VC RoundJun 1, 2019
Series A
Jul 23, 2017
View all Funding Rounds

Key People

Founding team and executive leadership

Guido Kurz

CEO

Executive Team

Agustí Soler Casas

Interin CFO Board Observer

Executive Team

Oncostellae Investors

Notable investors and investment history

InvestorRounds
InvereadyVC Round, Seed, Series A
Unirisco GaliciaVC Round, Series A
Innvierte Economía SostenibleSeries A
Bio&Tech Smart CapitalSeries A, VC Round
Center for Technological Development and InnovationVC Round, Grant
XesgaliciaVC Round, Seed, Series A
FitalentVC Round
View all Investors

Oncostellae Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Oncostellae Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Oncostellae's valuation, stock price, and market status.

Firmographic Details

HeadquartersSantiago de Compostela
Employee Range8
Year Founded2013
Last FundingJul 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.